Ceftaroline - A cause for neutropenia

Journal of Clinical Pharmacy and Therapeutics

Volumn 38, Issue 4, 2013, Pages 330-332

  Rimawi, R H ^a   Frenkel, A ^a   Cook, P P ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

agranulocytosis; antibiotics; ceftaroline; drug information; neutropenia

Indexed keywords

CEFTAROLINE; HEMOGLOBIN;

AGED; ALZHEIMER DISEASE; ANTIBIOTIC THERAPY; APPENDECTOMY; ARTICLE; CASE REPORT; COMPRESSION FRACTURE; DYSTHYMIA; FEMALE; FIBROMYALGIA; GASTROESOPHAGEAL REFLUX; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERLIPIDEMIA; HYSTERECTOMY; KYPHOPLASTY; LEUKOCYTE COUNT; LEUKOCYTOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUTROPENIA; PNEUMONIA; SPONDYLITIS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT;

AGRANULOCYTOSIS; ANTIBIOTICS; CEFTAROLINE; DRUG INFORMATION; NEUTROPENIA;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; FEMALE; HUMANS; NEUTROPENIA; PNEUMONIA, BACTERIAL;

EID: 84879911320     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12062     Document Type: Article

References (15)

1. Girish C, Balakrishnan S,. Ceftaroline fosamil: a novel anti-methicillin resistant S. aureus cephalosporin. J Pharmacol Pharmacother, 2011; 2: 209-211.
2. Duplessis C, Crum-Cianflone NF,. Ceftaroline: a new cephalosporin with activity against methicillin-resistant S. aureus (MRSA). Clin Med Rev Ther, 2011; 3: a2466.
3. Corey GR, Wilcox MH, Talbot GH, et al,. CANVAS 1: the first Phase III, randomized, double-blinded study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and soft tissue infections. J Antimicrob Chemother, 2011; 66 (Suppl. 3): iii19-iii32.
4. Wilcox MH, Corey GR, Talbot GH, et al,. CANVAS 2: the second Phase III, randomized, double-blinded study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and soft tissue infections. J Antimicrob Chemother, 2010; 65 (Suppl. 4): iv41-iv51.
5. File TM Jr, Low DE, Eckburg PB, et al,. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil vs. ceftriaxone for community-acquired pneumonia. J Antimicrob Chemother, 2010; 65 (Suppl. 4): iv53-iv65.
6. Low DE, File TM Jr, Eckburg PB, et al,. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil vs. ceftriaxone for community-acquired pneumonia. J Antimicrob Chemother, 2011; 66 (Suppl. 3): iii33-iii34.
7. CLSI, Surveillance for methicillin-resistant Staphylococcus aureus: principles, practices, and challenges; a report. CLSI document X07-R. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
8. Coates TD,. Drug-induced neutropenia and agranulocytosis. Available from http://www.uptodate.com/contents/drug-induced-neutropenia-and-agranulocytosis (accessed 27 November 2012).
9. Andersohn F, Konzen C, Garbe E,. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med, 2007; 146: 657.
10. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M,. Descriptive epidemiology of agranulocytosis. Arch Intern Med, 1992; 152: 1475.
11. Bain KT, Wittbrodt ET,. Linezolid for the treatment of resistant gram-positive Cocci. Ann Pharmacother, 2001; 35: 566-575.
12. Malincarne L, Francisci D, Martinelli L, Masini G, Baldelli F,. A case of severe cefepime-related neutropenia in a 15-year-old patient. Pediatr Blood Cancer, 2008; 51: 715-716.
13. Scheetz MH, McKoy JM, Parada JP, et al,. Systematic review of piperacillin-induced neutropenia. Drug Saf, 2007; 30: 295-306.
14. Peralta G, Sanchez-Santiago MB,. Beta-lactam-induced neutropenia. An old forgotten companion. Enferm Infecc Microbiol Clin, 2005; 23: 485-491.
15. Neftel KA, Hauser SP, Muller MR, Walti M,. Cephalosporin-induced neutropenia. Br J Haematol, 1986; 62: 394-397.